Access to the CNS: Biomarker Strategies for Dopaminergic Treatments

Despite substantial research carried out over the last decades, it remains difficult to understand the wide range of pharmacological effects of dopaminergic agents. The dopaminergic system is involved in several neurological disorders, such as Parkinson’s disease and schizophrenia. This complex syst...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Brink, Willem Johan, Palic, Semra, Köhler, Isabelle, de Lange, Elizabeth Cunera Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814527/
https://www.ncbi.nlm.nih.gov/pubmed/29450650
http://dx.doi.org/10.1007/s11095-017-2333-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814527/
https://www.ncbi.nlm.nih.gov/pubmed/29450650
http://dx.doi.org/10.1007/s11095-017-2333-x

Ejemplares similares